XTX202
XTX202-01/02-001
Phase 2 small_molecule completed
Quick answer
XTX202 for Advanced Solid Tumor is a Phase 2 program (small_molecule) at Xilio Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xilio Therapeutics
- Indication
- Advanced Solid Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed